OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy
Karin M. Knudson, SuJin Hwang, Mondona S. McCann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Karin M. Knudson, SuJin Hwang, Mondona S. McCann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer
Marta Jaén, Ángela Martín‐Regalado, Rubén A. Bartolomé, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188802-188802
Open Access | Times Cited: 26
Marta Jaén, Ángela Martín‐Regalado, Rubén A. Bartolomé, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188802-188802
Open Access | Times Cited: 26
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V. Lebedeva, Yu-Rou Liao, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268762-jnumed.124.268762
Closed Access
Leah Gajecki, Irina V. Lebedeva, Yu-Rou Liao, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268762-jnumed.124.268762
Closed Access
Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
Giorgiana Negrea, Valentin Florian Rauca, Marta Szilvia Meszaros, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Giorgiana Negrea, Valentin Florian Rauca, Marta Szilvia Meszaros, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates
Lei Yin, Aiyun Xu, Yumeng Zhao, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1324-1331
Open Access | Times Cited: 3
Lei Yin, Aiyun Xu, Yumeng Zhao, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1324-1331
Open Access | Times Cited: 3
Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating
Simona Roxana Georgescu, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1506-1506
Open Access | Times Cited: 5
Simona Roxana Georgescu, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1506-1506
Open Access | Times Cited: 5
Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo
Alina Sesărman, Lavinia Lupuţ, Valentin Florian Rauca, et al.
Journal of Liposome Research (2024) Vol. 34, Iss. 4, pp. 535-546
Closed Access
Alina Sesărman, Lavinia Lupuţ, Valentin Florian Rauca, et al.
Journal of Liposome Research (2024) Vol. 34, Iss. 4, pp. 535-546
Closed Access
Mouse models for cancer research – current state and the perspective
Katarina Gercakova, Martina Poturnajova, Silvia Tyčiaková, et al.
Neoplasma (2024) Vol. 71, Iss. 02, pp. 99-116
Open Access
Katarina Gercakova, Martina Poturnajova, Silvia Tyčiaková, et al.
Neoplasma (2024) Vol. 71, Iss. 02, pp. 99-116
Open Access
Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia
Sharareh Siamakpour‐Reihani, Felicia Cao, Jing Lyu, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268963-e0268963
Open Access | Times Cited: 1
Sharareh Siamakpour‐Reihani, Felicia Cao, Jing Lyu, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268963-e0268963
Open Access | Times Cited: 1
